Body mass index and effectiveness of reperfusion strategies: implications for the management of patients with ST-elevation myocardial infarction.

BACKGROUND Fibrinolytic therapy has maximum dose limit in patients with ST-elevation myocardial infarction (STEMI). Consequently, obese patients receive lower dose of fibrinolytic per kg body weight compared to lower weight patients. Whether the relatively lower dose results in lower effectiveness of fibrinolytic agents versus primary percutaneous coronary… CONTINUE READING